Lv11
70 积分 2023-10-10 加入
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial
6小时前
已完结
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales
6小时前
已完结
Eye Involvement and Management in Inherited Epidermolysis Bullosa
6小时前
求助中
Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa
1个月前
已完结
Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin Grafts
3个月前
已完结
Are existing validated severity scores for epidermolysis bullosa reflective of the burden of disease in patients with epidermolysis bullosa simplex?
3个月前
已完结
Knockout of IL-1R1 Reduced Inflammation and Improved Survival in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa
4个月前
已关闭
Treatment of multifactorial anaemia in adults with severe epidermolysis bullosa using intravenous ferric carboxymaltose: a single institution, observational, retrospective study
5个月前
已完结
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin
5个月前
已完结
Investigational Treatments for Epidermolysis Bullosa
5个月前
已完结
皖公网安备34019202002308
